Kedalion Thera

Menlo Park, United States Founded: 2015 • Age: 11 yrs Acquired By Novartis
Provider of drug delivery system for eye diseases

About Kedalion Thera

Kedalion Thera is a company based in Menlo Park (United States) founded in 2015 was acquired by Novartis in July 2022.. Kedalion Thera has raised $5 million across 2 funding rounds from investors including Novartis and Lagunita Biosciences. Kedalion Thera operates in a competitive market with competitors including Eyenovia, PolyActiva, iVeena Delivery Systems, Re-Vana Therapeutics and Everads Therapy, among others.

  • Headquarter Menlo Park, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $5 M (USD)

    in 2 rounds

  • Latest Funding Round
  • Investors
    Novartis

    & 1 more

  • Employee Count
    Employee Count
  • Acquired by
    Novartis

    (Jul 01, 2022)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Kedalion Thera

Kedalion Thera has successfully raised a total of $5M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round
  • First Round

    (06 Aug 2018)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Nov, 2021 Amount Series B - Kedalion Thera Valuation Novartis
Aug, 2018 Amount Series A - Kedalion Thera Valuation Lagunita Biosciences
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Kedalion Thera

Kedalion Thera has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Novartis and Lagunita Biosciences. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
R&D focused on manufacturing of drugs for multiple therapeutic areas
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Kedalion Thera

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Kedalion Thera

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Kedalion Thera Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Kedalion Thera

Kedalion Thera operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Eyenovia, PolyActiva, iVeena Delivery Systems, Re-Vana Therapeutics and Everads Therapy, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Microdose therapies for myopia treatment are developed with Optejet dispenser.
domain founded_year HQ Location
A platform for slow-release, site-specific drug delivery is developed.
domain founded_year HQ Location
Ocular drug products for drop-free cataract surgery are developed.
domain founded_year HQ Location
Drug delivery platform for ophthalmic diseases is developed.
domain founded_year HQ Location
Drug & a cell targeting system for posterior segment eye diseases
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Kedalion Thera

Frequently Asked Questions about Kedalion Thera

When was Kedalion Thera founded?

Kedalion Thera was founded in 2015 and raised its 1st funding round 3 years after it was founded.

Where is Kedalion Thera located?

Kedalion Thera is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.

Is Kedalion Thera a funded company?

Kedalion Thera is a funded company, having raised a total of $5M across 2 funding rounds to date. The company's 1st funding round was a Series A of $5M, raised on Aug 06, 2018.

What does Kedalion Thera do?

Provider of drug delivery system for eye diseases. The companys AcuStream technology is for delivering topical drugs to the eye. The company claims that the system will reduce the rate of overdose, administration error, contamination, and discontinuation rate.

Who are the top competitors of Kedalion Thera?

Kedalion Thera's top competitors include Eyenovia, PolyActiva and iVeena Delivery Systems.

Who are Kedalion Thera's investors?

Kedalion Thera has 2 investors. Key investors include Novartis, and Lagunita Biosciences.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available